The citations below is a result of Institute for Scientific Information Science Citation Index search

Citing Article

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins

Koudinov AR, Koudinova NV, Kumar A, et al.
223: (3) 592-597 JUN 25 1996

51 papers by July 20, 2001

(please note: selected papers provide links to the PubMed abstracts)


Koudinov AR, Koudinova NV
    Essential role for cholesterol in synaptic plasticity and neuronal degeneration

FASEB J 15 (8): U181-U204 JUN 2001

Beisiegel U, Spector AA
    Lipids and lipoproteins in the brain
CURR OPIN LIPIDOL 12 (3): 243-244 JUN 2001

Kontush A, Berndt C, Weber W, et al.
    Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
FREE RADICAL BIO MED 30: (1) 119-128 JAN 1 2001

Munson GW, Roher AE, Kuo YM, et al.
SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides
BIOCHEMISTRY-US 39: (51) 16119-16124 DEC 26 2000

Danik M, Champagne D, Petit-Turcotte C, et al.
    Brain lipoprotein metabolism and its relation to neurodegenerative disease
CRIT REV NEUROBIOL 13: (4) 357-407 1999

Fagan AM, Holtzman DM
    Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo
MICROSC RES TECHNIQ 50: (4) 297-304 AUG 15 2000

Calero M, Rostagno A, Matsubara E, et al.
    Apolipoprotein J (clusterin) and Alzheimer's disease
MICROSC RES TECHNIQ 50: (4) 305-315 AUG 15 2000

Cole GM, Ard MD
    Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein
MICROSC RES TECHNIQ 50: (4) 316-324 AUG 15 2000

Fagan AM, Younkin LH, Morris JC, et al.
    Differences in the A beta 40/A beta 42 ratio associated with cerebrospinal fluid lipoproteins as a function of
    apolipoprotein E genotype
ANN NEUROL 48: (2) 201-210 AUG 2000

Jensen M, Hartmann T, Engvall B, et al.
    Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems
MOL MED 6: (4) 291-302 APR 2000

Koudinova NV, Koudinov AR, Yavin E
    Alzheimer's A beta(1-40) peptide modulates lipid synthesis in neuronal cultures and intact rat fetal brain under normoxic and oxidative stress conditions
NEUROCHEM RES 25: (5) 653-660 MAY 2000


LaDu MJ, Reardon C, Van Eldik L, et al.
    Lipoproteins in the central nervous system
ANN NY ACAD SCI 903: 167-175 2000

Demeester N, Castro G, Desrumaux C, et al.
    Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin : cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease
J LIPID RES 41: (6) 963-974 JUN 2000

Fukuyama R, Mizuno T, Mori S, et al.
    Age-dependent decline in the apolipoprotein e level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease
EUR NEUROL 43: (3) 161-169 2000

Olesen OF, Dago L

    High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils
BIOCHEM BIOPH RES COM 270: (1) 62-66 APR 2 2000

Schippling S, Kontush A, Arlt S, et al.
    Increased lipoprotein oxidation in Alzheimer's disease
FREE RADICAL BIO MED 28: (3) 351-360 FEB 1 2000

Heininger K
    A unifying hypothesis of Alzheimer's disease. III. Risk factors
HUM PSYCHOPHARM CLIN 15: (1) 1-70 JAN 2000

Koudinov AR, Koudinova NV, Berezov TT, et al.

HDL phospholipid: a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis?

CLIN CHEM LAB MED 37: (10) 993-994 OCT 1999
Tomiyama T, Corder EH, Mori H
Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease

CELL MOL LIFE SCI 56: (3-4) 268-279 OCT 15 1999
Fagan AM, Holtzman DM, Munson G, et al.
Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice

J BIOL CHEM 274: (42) 30001-30007 OCT 15 1999
Scharnagl H, Tisljar U, Winkler K, et al.
The beta A4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway

LAB INVEST 79: (10) 1271-1286 OCT 1999

Cole GM, Beech W, Frautschy SA, et al.
Lipoprotein effects on A beta accumulation and degradation by microglia in vitro

J NEUROSCI RES 57: (4) 504-520 AUG 15 1999
Roher AE, Kuo YM, Kokjohn KM, et al.
Amyloid and lipids in the pathology of Alzheimer disease

AMYLOID 6: (2) 136-145 JUN 1999
Koudinova NV, Berezov TT, Koudinov AR
beta-amyloid: Alzheimer's disease and brain beta-amyloidoses

BIOCHEMISTRY-MOSCOW+ 64: (7) 752-757 JUL 1999
Mulder M, Terwel D
Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?

HAEMOSTASIS 28: (3-4) 174-194 MAY-AUG 1998
Kuo YM, Emmerling MR, Lampert HC, et al.
High levels of circulating A beta 42 are sequestered by plasma proteins in Alzheimer's disease

BIOCHEM BIOPH RES CO 257: (3) 787-791 APR 21 1999
Kowalewski T, Holtzman DM
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: New insights into mechanism of beta-sheet formation

P NATL ACAD SCI USA 96: (7) 3688-3693 MAR 30 1999
Holtzman DM, Bales KR, Wu S, et al.
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

J CLIN INVEST 103: (6) R15-R21 MAR 1999
Shao HY, Jao SC, Ma K, et al.
Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease

J MOL BIOL 285: (2) 755-773 JAN 15 1999
Bernoud N, Fenart L, Moliere P, et al.
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid

J NEUROCHEM 72: (1) 338-345 JAN 1999
Marcinowski KJ, Shao H, Clancy EL, et al.
Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles

J AM CHEM SOC 120: (43) 11082-11091 NOV 4 1998

Frautschy SA, Horn DL, Sigel JJ, et al.
Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain

J NEUROSCI 18: (20) 8311-8321 OCT 15 1998
Kaplan B
Application of polyacrylamide slab gel electrophoresis to the analysis and small-scale purification of amyloid proteins

ANAL CHIM ACTA 372: (1-2) 161-172 OCT 19 1998
Bernoud N, Fenart L, Benistant C, et al.
Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro

J LIPID RES 39: (9) 1816-1824 SEP 1998
Holtzman DM, Fagan AM
Potential role of apoE in structural plasticity in the nervous system - Implications for disorders of the central nervous system

TRENDS CARDIOVAS MED 8: (6) 250-255 AUG 1998
Koudinov AR, Berezov TT, Koudinova NV
Alzheimer's amyloid beta and lipid metabolism: a missing link?

FASEB J 12: (12) 1097-1099 SEP 1998
Beffert U, Danik M, Krzywkowski P, et al.
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

BRAIN RES REV 27: (2) 119-142 JUL 1998
Fagan AM, Murphy BA, Patel SN, et al.
Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury

EXP NEUROL 151: (2) 314-325 JUN 1998
Kudinova NV, Beavis RC, Berezov TT, et al.
Isolation and characterization of soluble beta-amyloid and apolipoproteins from cerebrospinal fluid

B EXP BIOL MED+ 124: (10) 995-998 OCT 1997
Koudinova NV, Berezov TT, Koudinov AR
Alzheimer's disease: Beta amyloid and lipid metabolism.

VOP MED KHIM 44: (1) 28-34 JAN-FEB 1998
LaDu MJ, Gilligan SM, Lukens JR, et al.
Nascent astrocyte particles differ from lipoproteins in CSF

J NEUROCHEM 70: (5) 2070-2081 MAY 1998

Sun YL, Wu S, Bu GJ, et al.
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins

J NEUROSCI 18: (9) 3261-3272 MAY 1 1998
Koudinov AR, Berezov TT, Kumar A, et al.
Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids

CLIN CHIM ACTA 270: (2) 75-84 FEB 23 1998
Rebeck GW, Alonzo NC, Berezovska O, et al.
Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes

EXP NEUROL 149: (1) 175-182 JAN 1998
Urmoneit B, Prikulis I, Wihl G, et al.
Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy

LAB INVEST 77: (2) 157-166 AUG 1997
Koudinov AR, Koudinova NV
Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein

CELL BIOL INT 21: (5) 265-271 MAY 1997
LaDu MJ, Lukens JR, Reardon CA, et al.
Association of human, rat, and rabbit apolipoprotein E with beta-amyloid

J NEUROSCI RES 49: (1) 9-18 JUL 1 1997
Farhangrazi ZS, Ying H, Bu GJ, et al.
High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture

NEUROREPORT 8: (5) 1127-1130 MAR 24 1997
Puttfarcken PS, Manelli AM, Falduto MT, et al.
Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures

J NEUROCHEM 68: (2) 760-769 FEB 1997
Carroll JA, Beavis RC
Using matrix convolution filters to extract information from time-of-flight mass spectra

RAPID COMMUN MASS SP 10: (13) 1683-1687 1996
Koudinova NV, Berezov TT, Koudinov AR
Multiple inhibitory effects of Alzheimer's peptide A beta 1-40 on lipid biosynthesis in cultured human HepG2 cells

FEBS LETT 395: (2-3) 204-206 OCT 21 1996

Thanks for visiting Drs. Koudinov Internet Office

Site Design and Programming © Alexei Koudinov, 2001. Last updated: July 20, 2001